Tuberculosis Market Research Reports & Industry Analysis
The Mantoux test is used in the United States and is endorsed by the American Thoracic Society and Centers for Disease Control and Prevention (CDC). Multiple puncture tests such as the Tine test are not recommended. The Mantoux test is one of the two major tuberculin skin tests for tuberculosis used in the world.
As a replacement for the Mantoux test, several other tests are being developed. QuantiFERON®-TB Gold, manufactured by Cellestis Limited (Carnegie, Victoria, Australia) is a blood test that measures the patient’s immune reactivity to the M. tuberculosis and is useful for initial and serial testing of persons with an increased risk of latent or active tuberculosis infection. Guidelines for the use of QuantiFERON-®TB Gold were released by the CDC in December of 2005. QuantiFERON®-TB Gold is FDA approved in the United States; has CE Mark approval in Europe; and has been approved by the MHLW in Japan. Sputum smears and cultures should be done for acid-fast bacilli if the patient is producing sputum. The preferred method for this is fluorescence microscopy (auramine-rhodamine staining), which is more sensitive than conventional Ziehl- Neelsen staining.
Tuberculosis Industry Research & Market Reports
-
The 2025-2030 World Outlook for Respiratory Diagnostics for Tuberculosis
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Communicable Diseases
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Tuberculosis Testing
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
Respiratory Diagnostics Market Report by Product and Service Type (Instruments and Services, Assays and Reagents, Services and Software), Test Type (Mechanical Tests, Obstructive Sleep Apnoea (OSA) Diagnostic Tests, Imaging Tests, Traditional Diagnostic Tests, Molecular Diagnostic Tests, and Others), Disease (Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease (COPD), Lung Cancer, and Others), End-User (Hospitals, Clinics, Reference and Clinical Laboratories, and Others), and Region 2024-2032
... Tests, and Others), Disease (Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease (COPD), Lung Cancer, and Others), End-User (Hospitals, Clinics, Reference and Clinical Laboratories, and Others), and Region 2024-2032 The global respiratory diagnostics market size reached US$ ... Read More
-
The Market and Future Potential for Molecular Point-of-Care (mPOC), 11th Edition
... units, physician offices, outpatient clinics, and community health posts, aiming to assess conditions or admit patients accurately. The concept blends the accessibility of point-of-care (POC) testing with the precision of molecular technology. Kalorama Information has ... Read More
-
Lateral Flow Assay Market by Product (Kit, Readers), Application (STI, Covid-19, Hep, TB, Cardiac marker, Pregnancy; Drug abuse, Vet Diaganostic, Food), Sample (Blood, Urine, Saliva), Technique (Sandwich, Competitive), End User - Global Forecast to 2029
... The lateral flow assays market is valued at an estimated USD 10.8 billion in 2023 and is projected treach USD 16.8 billion by 2029, at a CAGR of 7.6% during the forecast period. The rising ... Read More
-
Tuberculosis Diagnostics Global Market Report 2024
... Tests Test Types 2) By Disease Stage: Latent Tuberculosis; Active Tuberculosis 3) By End-User: Hospitals And Diagnostic Laboratories; Physician’s Office Laboratories; Reference Laboratories; Academics And Research Facilities Covering: Beckton, Dickinson and Company; F. Hoffmann-La Roche ... Read More
-
Tuberculosis Diagnostics Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029
... forecast period with a CAGR of 4.50% through 2029. Tuberculosis (TB) is a bacterial infection caused by Mycobacterium tuberculosis, a bacterium that primarily affects the lungs but can also infect other parts of the body. ... Read More
-
Middle East & Africa Bovine Diagnostics Market Forecast to 2030 – Regional Analysis – by Product [Immunoassay Kits, PCR Reagents & Kits, Hemagglutination Inhibition (HI) Assay, and Other Products], Disease Type [Bovine Viral Diarrhea (BVD), Bovine Tuberculosis (TB), Bovine Mastitis, Foot and Mouth Disease (FMD), and Other Disease Type], and End User (Veterinary Hospitals, Veterinary Clinics, and Other End-Users)
... Bovine Tuberculosis (TB), Bovine Mastitis, Foot and Mouth Disease (FMD), and Other Disease Type], and End User (Veterinary Hospitals, Veterinary Clinics, and Other End-Users) The Middle East & Africa bovine diagnostics market is expected to ... Read More
-
Asia Pacific Bovine Diagnostics Market Forecast to 2030 – Regional Analysis – by Product [Immunoassay Kits, PCR Reagents & Kits, Hemagglutination Inhibition (HI) Assay, and Other Products], Disease Type [Bovine Viral Diarrhea (BVD), Bovine Tuberculosis (TB), Bovine Mastitis, Foot and Mouth Disease (FMD), and Other Disease Type], and End User (Veterinary Hospitals, Veterinary Clinics, and Other End-Users)
... (TB), Bovine Mastitis, Foot and Mouth Disease (FMD), and Other Disease Type], and End User (Veterinary Hospitals, Veterinary Clinics, and Other End-Users) The Asia Pacific bovine diagnostics market is expected to grow from US$ 250.42 ... Read More
-
Europe Bovine Diagnostics Market Forecast to 2030 – Regional Analysis – by Product [Immunoassay Kits, PCR Reagents & Kits, Hemagglutination Inhibition (HI) Assay, and Other Products], Disease Type [Bovine Viral Diarrhea (BVD), Bovine Tuberculosis (TB), Bovine Mastitis, Foot and Mouth Disease (FMD), and Other Disease Type], and End User (Veterinary Hospitals, Veterinary Clinics, and Other End-Users)
... Bovine Mastitis, Foot and Mouth Disease (FMD), and Other Disease Type], and End User (Veterinary Hospitals, Veterinary Clinics, and Other End-Users) The Europe bovine diagnostics market is expected to grow from US$ 301.31 million in ... Read More
-
North America Bovine Diagnostics Market Forecast to 2030 – Regional Analysis – by Product [Immunoassay Kits, PCR Reagents & Kits, Hemagglutination Inhibition (HI) Assay, and Other Products], Disease Type [Bovine Viral Diarrhea (BVD), Bovine Tuberculosis (TB), Bovine Mastitis, Foot and Mouth Disease (FMD), and Other Disease Type], and End User (Veterinary Hospitals, Veterinary Clinics, and Other End-Users)
... (TB), Bovine Mastitis, Foot and Mouth Disease (FMD), and Other Disease Type], and End User (Veterinary Hospitals, Veterinary Clinics, and Other End-Users) The North America bovine diagnostics market is expected to grow from US$ 443.82 ... Read More
-
South & Central America Bovine Diagnostics Market Forecast to 2030 – Regional Analysis – by Product [Immunoassay Kits, PCR Reagents & Kits, Hemagglutination Inhibition (HI) Assay, and Other Products], Disease Type [Bovine Viral Diarrhea (BVD), Bovine Tuberculosis (TB), Bovine Mastitis, Foot and Mouth Disease (FMD), and Other Disease Type], and End User (Veterinary Hospitals, Veterinary Clinics, and Other End-Users)
... Bovine Tuberculosis (TB), Bovine Mastitis, Foot and Mouth Disease (FMD), and Other Disease Type], and End User (Veterinary Hospitals, Veterinary Clinics, and Other End-Users) The South & Central America bovine diagnostics market is expected to ... Read More
-
Tuberculosis Drugs Market by Disease (Active TB, Latent TB), Drug Class (Combination Drugs, First-line Anti-TB Drugs, Second-line Anti-TB Drugs) - Global Forecast 2024-2030
... 2023 and expected to reach USD 2.04 billion in 2024, at a CAGR 6.28% to reach USD 2.95 billion by 2030. Global Tuberculosis Drugs Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Zoonotic Disease Treatment Market by Disease Type (Rabies, Tuberculosis, Viral Hepatitis), Drug Class (Antibacterial Medication, Antibiotics) - Global Forecast 2024-2030
... expected to reach USD 42.99 billion in 2024, at a CAGR 5.45% to reach USD 59.18 billion by 2030. Global Zoonotic Disease Treatment Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Tuberculosis Testing Market by Test (Culture Based Tests, Drug Susceptibility Testing, Nucleic Acid Testing), End User (Hospital, Laboratories) - Global Forecast 2024-2030
... and expected to reach USD 2.76 billion in 2024, at a CAGR 7.38% to reach USD 4.23 billion by 2030. Global Tuberculosis Testing Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Tuberculosis Diagnostics Market by Test Type (Drug-susceptibility Testing, Laboratory Methods, Mantoux Test), Type (Point-of-Care Technologies, Rapid Test), End_User - Global Forecast 2024-2030
... and expected to reach USD 3.17 billion in 2024, at a CAGR 5.48% to reach USD 4.38 billion by 2030. Global Tuberculosis Diagnostics Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Global Tuberculosis (TB) Diagnostics Market Research Report 2024(Status and Outlook)
... other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about ... Read More
-
Global Tuberculosis Therapeutics Market Research Report 2024(Status and Outlook)
... show no symptoms, in which case it is known as latenttuberculosis. The Global Tuberculosis Therapeutics Market Size was estimated at USD 709.17 million in 2023 and is projected to reach USD 841.86 million by 2029, ... Read More
-
Global Nontuberculous Mycobacterial Infections Market 2024-2028
... mycobacterial infections market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market ... Read More
-
Global Tuberculosis (TB) Drugs/Therapeutics Market Professional Survey by Types, Applications, and Players, with Regional Growth Rate Analysis and Development Situation, from 2023 to 2028
... growth of the Tuberculosis (TB) Drugs/Therapeutics industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Tuberculosis (TB) Drugs/Therapeutics. The report also introduces players ... Read More
-
Tuberculosis Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2028
... Test, Drug Resistance Test, And Others), End-User (Hospitals And Clinics, Diagnostic Centers, And Others), and geography is expected to grow at a steady CAGR forecast till 2028 owing to the increasing prevalence of tuberculosis and ... Read More
-
Global Latent TB Testing Market (2023 Edition)
... Latent TB Testing Market (2023 Edition)” which provides a complete analysis of the Global Latent TB Testing industry in terms of market segmentation By Test Type (Tuberculin Skin Test -TST, Interferon Gamma Released Assay -IGRA), ... Read More
-
Diagnostic Specialty Antibodies Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Antibody (Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Polyclonal Antibodies), By Application (Dengue Diagnostics, HIV Diagnostics, Hepatitis Diagnosis, Infectious Disease Diagnostics, Oncology Diagnostics, Tuberculosis Diagnostics), By End User (Diagnostic Laboratories, Hospitals, Others), By Region, and Competition
... Oncology Diagnostics, Tuberculosis Diagnostics), By End User (Diagnostic Laboratories, Hospitals, Others), By Region, and Competition Global Diagnostic Specialty Antibodies Market is anticipated to project impressive growth in the forecast period. The Global Diagnostic Specialty Antibodies ... Read More
-
Bovine Tuberculosis Diagnosis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Tests (Molecular Diagnostic Tests, Serological Tests, Traditional Tests), By Region, By Competition
... at USD 735.27 million in 2022 and is anticipated to project impressive growth in the forecast period with a CAGR of 4.81% through 2028. The Global Bovine Tuberculosis Diagnosis Market is a dynamic and evolving ... Read More
Research Assistance
